Literature DB >> 24290925

Optimal drug regimens in cancer chemotherapy: a multi-objective approach.

Yazdan Batmani1, Hamid Khaloozadeh.   

Abstract

In this paper, based on two mathematical models, a set of optimal anticancer drug regimens is designed. Two important difficulties in treating cancers with chemotherapy are drug resistance and toxicity. They were considered in our treatment design; a compartmental model was extended to appropriately describe drug resistance and two constraints were imposed on the value of the anticancer drug dynamics to avoid toxicity. Indeed, we optimized two objective functions simultaneously in order to minimize the size of the tumor as well as the side effects of the anticancer drug on the patient's body. Operating the described task, a bi-objective optimization problem was defined and solved by an evolutionary method. This optimization led to a set of optimal drug regimens, which can be used in several chemotherapy treatments. Numerical simulations were given to illustrate the flexibility of the method.
© 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer chemotherapy; Compartmental model; Drug resistance; Multi-objective optimization; Toxicity

Mesh:

Substances:

Year:  2013        PMID: 24290925     DOI: 10.1016/j.compbiomed.2013.09.026

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  3 in total

1.  Differences in predictions of ODE models of tumor growth: a cautionary example.

Authors:  Hope Murphy; Hana Jaafari; Hana M Dobrovolny
Journal:  BMC Cancer       Date:  2016-02-26       Impact factor: 4.430

Review 2.  Nanotechnologies in Pancreatic Cancer Therapy.

Authors:  Ayesha Manzur; Adeolu Oluwasanmi; Darren Moss; Anthony Curtis; Clare Hoskins
Journal:  Pharmaceutics       Date:  2017-09-25       Impact factor: 6.321

3.  Pretomanid dose selection for pulmonary tuberculosis: An application of multi-objective optimization to dosage regimen design.

Authors:  Michael A Lyons
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.